Natural history and clinical outcomes in patients with Alzheimer's disease–related psychosis by antipsychotic treatment status in the United States
Antipsychotic initiators with ADP had a higher burden of some baseline comorbidities; experienced higher incidence of falls, fractures, and mortality; and had lower incidence of seizure/epilepsy than antipsychotic nonusers.
Authors
- Brian Calingaert (ORCID: https://orcid.org/0000-0001-8177-6326)
- Colleen Dempsey
- Sapna Rao (ORCID: https://orcid.org/0000-0003-4868-6788)
- Sanjeev Pathak (ORCID: https://orcid.org/0000-0001-5842-690X)
- Mary S. Anthony (ORCID: https://orcid.org/0000-0002-5201-1794)
- J. Bradley Layton (ORCID: https://orcid.org/0000-0003-0994-5820)
- Joan Forns (ORCID: https://orcid.org/0000-0002-1066-0358)
- Heather E. Danysh (ORCID: https://orcid.org/0000-0003-3014-7508)
- Thomas Aquilina
Institutions
- Acadia Pharmaceuticals (United States) (US)
- RTI Health Solutions (US)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1177/13872877241297361
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- ACADIA Pharmaceuticals